Douglas S. Annis
Impact in
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
Papers in
-
- Angiogenesis and VEGF in Cancer 20
-
- Cell Adhesion Molecules Research 28
- Co-authors
- Deane F. Mosher (61 shared papers)Thomas J. Kunicki (6 shared papers)David D. Roberts (6 shared papers)Mats W. Johansson (8 shared papers)Diane J. Nugent (2 shared papers)Marcie Kritzik (1 shared paper)Jack Lawler (3 shared papers)Henry C. Krutzsch (4 shared papers)
- Journals
- Journal of Biological Chemistry (25 papers)PLoS ONE (5 papers)Blood (3 papers)Biochemistry (3 papers)The EMBO Journal (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Douglas S. Annis
71 papers receiving 3.7k citations
Douglas S. Annis's Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology and Allergy 716
- Cancer Research 650
- Developmental Neuroscience 147
- Hematology 394
- Neurology 236
Countries citing papers authored by Douglas S. Annis
This map shows the geographic impact of Douglas S. Annis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Annis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Annis more than expected).
Fields of papers citing papers by Douglas S. Annis
This network shows the impact of papers produced by Douglas S. Annis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Annis. The network helps show where Douglas S. Annis may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas S. Annis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis Hit paper breakdown → | 2009 | 712 |
| 2 | 1997 | 224 | |
| 3 | 2008 | 197 | |
| 4 | 2006 | 171 | |
| 5 | 2002 | 125 | |
| 6 | 2008 | 117 | |
| 7 | 2013 | 100 | |
| 8 | 1997 | 95 | |
| 9 | 2015 | 90 | |
| 10 | 2003 | 85 | |
| 11 | 2003 | 83 | |
| 12 | 2004 | 79 | |
| 13 | 2002 | 74 | |
| 14 | 2005 | 74 | |
| 15 | 2009 | 69 | |
| 16 | 2010 | 63 | |
| 17 | 2007 | 55 | |
| 18 | 2010 | 54 | |
| 19 | 2004 | 50 | |
| 20 | 2018 | 50 |
About Douglas S. Annis
Douglas S. Annis is a scholar working on Molecular Biology, Immunology and Allergy, Cancer Research, Hematology and Cell Biology, having authored 72 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (28 papers), Angiogenesis and VEGF in Cancer (20 papers), Protease and Inhibitor Mechanisms (18 papers), Platelet Disorders and Treatments (15 papers), Proteoglycans and glycosaminoglycans research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Connective tissue disorders research (5 papers) and Streptococcal Infections and Treatments (4 papers). The work is most often cited by research in Immunology and Allergy (716 citations), Cancer Research (650 citations), Developmental Neuroscience (147 citations), Hematology (394 citations) and Neurology (236 citations). Douglas S. Annis has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Deane F. Mosher, Thomas J. Kunicki, David D. Roberts, Mats W. Johansson, Diane J. Nugent, Marcie Kritzik, Jack Lawler, Henry C. Krutzsch, Marı́a J. Calzada and Tina M. Misenheimer. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE, Blood, Biochemistry and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.